Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Gethings

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|July 27, 2019
Simplifying the Proteome: Analytical Strategies for Improving Peak CapacityLee A Gethings, Joanne B Connolly
Advances in Experimental Medicine and Biology|June 22, 2014
Simplifying the proteome: analytical strategies for improving peak capacityLee A Gethings, Joanne B Connolly
Journal of Separation Science|May 6, 2025
A HILIC-IM-MS-Based Pharmacometabodynamic Study of the Effects of Orally Administered Gefitinib on the Polar Urinary Metabolic Phenotypes of C57Bl6 MiceAdam King, Lee A Gethings, Robert S Plumb, et al.
Zeitschrift Fur Anorganische Und Allgemeine Chemie|May 22, 2015
Conformational Study of an Artificial Metal-Dependent Regulation Site for Use in Designer ProteinsEmmanuel Oheix, Neil Spencer, Lee A Gethings, et al.
Journal of Proteome Research|June 13, 2026
Maximizing Lipidome Coverage of Mouse Liver Following the IV Administration of Gefitinib by Combining Both UHPLC-MS-Based Untargeted and Targeted LipidomicsRobert S Plumb, Nyasha Munjoma, Lee A Gethings, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 4, 2021
Proteomic consequences of the deletion of cytochrome P450 (CYP450) reductase in miceLee A Gethings, Nicola Gray, Robert S Plumb, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2020
UHPLC-MS-Based Lipidomic and Metabonomic Investigation of the Metabolic Phenotypes of Wild Type and Hepatic CYP Reductase Null (HRN) MiceNicola Gray, Lee A Gethings, Robert S Plumb, et al.
Journal of Chromatography. A|May 1, 2022
Access to the Phospho-proteome via the Mitigation of Peptide-Metal InteractionsChristopher J Hughes, Lee A Gethings, Ian D Wilson, et al.
Scientific Reports|July 24, 2024
Detection of pharmacolipidodynamic effects following the intravenous and oral administration of gefitinib to C57Bl/6JRj mice by rapid UHPLC-MS analysis of plasmaRobert S Plumb, Lee A Gethings, Giorgis Isaac, et al.
Metabolites|March 29, 2023
Lipidomic Analysis Reveals Differences in <i>Bacteroides</i> Species Driven Largely by Plasmalogens, Glycerophosphoinositols and Certain SphingolipidsEileen Ryan, Belén Gonzalez Pastor, Lee A Gethings, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|July 27, 2019
Simplifying the Proteome: Analytical Strategies for Improving Peak CapacityLee A Gethings, Joanne B Connolly
Advances in Experimental Medicine and Biology|June 22, 2014
Simplifying the proteome: analytical strategies for improving peak capacityLee A Gethings, Joanne B Connolly
Journal of Separation Science|May 6, 2025
A HILIC-IM-MS-Based Pharmacometabodynamic Study of the Effects of Orally Administered Gefitinib on the Polar Urinary Metabolic Phenotypes of C57Bl6 MiceAdam King, Lee A Gethings, Robert S Plumb, et al.
Zeitschrift Fur Anorganische Und Allgemeine Chemie|May 22, 2015
Conformational Study of an Artificial Metal-Dependent Regulation Site for Use in Designer ProteinsEmmanuel Oheix, Neil Spencer, Lee A Gethings, et al.
Journal of Proteome Research|June 13, 2026
Maximizing Lipidome Coverage of Mouse Liver Following the IV Administration of Gefitinib by Combining Both UHPLC-MS-Based Untargeted and Targeted LipidomicsRobert S Plumb, Nyasha Munjoma, Lee A Gethings, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 4, 2021
Proteomic consequences of the deletion of cytochrome P450 (CYP450) reductase in miceLee A Gethings, Nicola Gray, Robert S Plumb, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2020
UHPLC-MS-Based Lipidomic and Metabonomic Investigation of the Metabolic Phenotypes of Wild Type and Hepatic CYP Reductase Null (HRN) MiceNicola Gray, Lee A Gethings, Robert S Plumb, et al.
Journal of Chromatography. A|May 1, 2022
Access to the Phospho-proteome via the Mitigation of Peptide-Metal InteractionsChristopher J Hughes, Lee A Gethings, Ian D Wilson, et al.
Scientific Reports|July 24, 2024
Detection of pharmacolipidodynamic effects following the intravenous and oral administration of gefitinib to C57Bl/6JRj mice by rapid UHPLC-MS analysis of plasmaRobert S Plumb, Lee A Gethings, Giorgis Isaac, et al.
Metabolites|March 29, 2023
Lipidomic Analysis Reveals Differences in <i>Bacteroides</i> Species Driven Largely by Plasmalogens, Glycerophosphoinositols and Certain SphingolipidsEileen Ryan, Belén Gonzalez Pastor, Lee A Gethings, et al.
Pageof 6